Hong Kong Stock Exchange: A dual listing opportunity for Canadian issuers

The Hong Kong Stock Exchange (HKEX) has re-emerged as a leading global IPO venue, offering Canadian companies, particularly those in the technology, industrial, mining, and consumer sectors, a compelling opportunity to access a broader pool of Chinese and Asian institutional and retail capital. Whether as a dual listing alongside the TSX or as a primary listing, HKEX offers meaningful liquidity, strong aftermarket support, and a regulatory framework that is increasingly accommodating to international issuers.

This note summarizes key developments in Hong Kong capital markets in 2025 and outlines why Canadian boards and management teams should consider the HKEX as part of their broader capital markets strategy.

Hong Kong’s record-breaking numbers in 2025

HKEX was the top global IPO venue in 2025, raising approximately US$37.4 billion in IPO proceeds across 115 IPOs, including eight transactions exceeding US$1 billion, which included two of the five largest IPOs globally.

The HKEX ranked as the third-largest market for equity fundraising in 2025, with 570 transactions raising approximately US$103.4 billion, behind only NASDAQ and the NYSE. The HKEX was also the second most active market for follow-on offerings, where listed companies raised approximately US$66.0 billion through secondary share sales.

Strong IPO aftermarket

One of the most notable features of the Hong Kong market in 2025 was the strength of the IPO aftermarket. The average share price performance of Hong Kong IPOs (with deal sizes of US$500 million or above) significantly outperformed equivalent IPOs on US, European, and broader Asia-Pacific exchanges (Bloomberg). Hong Kong IPOs delivered an average return of approximately 32.2% from IPO to current price compared to 20.5% for the broader Asia-Pacific region (excluding Hong Kong and Chinese Mainland), 13.0% for Europe, and 10.2% for the United States (Bloomberg).

Sectors aligned with Canadian issuers

HKEX’s 2025 pipeline was concentrated in sectors that closely align with the strengths of many Canadian issuers, particularly energy, mining, and technology.

Metals and mining were one of the most active sectors on the HKEX in 2025, driven by strong Asian institutional investor demand for precious metals, battery materials, and critical minerals linked to electrification. The exchange hosted the largest mining IPO since 2012, which raised $3.7 billion for a Chinese gold producer with principal mining assets across Central Asia and Africa. The Hong Kong retail tranche of this IPO was reportedly more than 240 times oversubscribed, while institutional demand exceeded 20 times the shares available, highlighting strong investor appetite for mining companies on the HKEX.

For Canadian mining issuers, particularly those with producing assets, offtake counterparties, or strategic investors in Asia, HKEX provides the opportunity to diversify their shareholder base. A HKEX listing may also enhance visibility with Chinese and Asian investors for potential M&A, strategic investments, and joint ventures at a time when global competition for critical minerals and supply chain security has intensified.

Industrials and energy accounted for approximately 38% of HKEX IPO volume in 2025, making it the largest sector on the exchange by issuance volume. This included two of the largest industrial IPOs globally in 2025, which raised US$2.0 billion and US$1.4 billion, respectively (Dealogic and Bloomberg). This signals investor demand for capital-intensive and infrastructure-oriented businesses, sectors that are well represented on the TSX.

Consumer HKEX was the leading global market for consumer-sector IPOs in 2025, raising approximately US$4.9 billion in IPO proceeds. For Canadian consumer brands, particularly those with existing operations, distribution networks, or brand presence in Asia, HKEX provides access to a large and active retail investor base with an appetite for consumer brands, while also serving as a platform for enhanced brand visibility and supporting regional growth initiatives across Asia.

Technology, media, and telecommunications (TMT) represented approximately 21% of 2025 IPO volume, with an additional pipeline of approximately 114 TMT companies and 32 biotech companies. For Canadian technology and life science companies, particularly those with commercial partnerships, manufacturing relationships, and growth strategies tied to Asia, the HKEX could be an ideal listing platform for raising growth capital. In addition, for life science companies specifically, a HKEX listing may also provide greater proximity to the Chinese pharmaceutical market, one of the world’s largest and fastest-growing healthcare markets, as well as increased visibility with Asian healthcare investors, strategic partners, and commercial partners.

The launch of the Technology Enterprises Channel (TECH) in 2025, a joint initiative by the Securities and Futures Commission (SFC) and HKEX, is aimed at specialist technology and biotech companies seeking a listing under Chapters 18A and 18C of the listing rules. The initiative introduces a streamlined listing process, including dedicated regulatory review teams, confidential filing options, and simplified requirements for qualifying innovation companies (HKEX and SFC).

International issuers

Hong Kong is no longer a market focused exclusively on Greater China issuers. Seven international issuer IPOs were completed in 2025, representing companies domiciled in Indonesia, Singapore, Thailand, Kazakhstan, the UAE, and the United States. These international listings cover a range of sectors, including mining, biotech, consumer goods, and healthcare, and have delivered strong aftermarket performance.

HKEX also expanded its international connectivity and issuer reach. In 2025, HKEX added the Stock Exchange of Thailand as a Recognised Stock Exchange, signed an MOU with the Abu Dhabi Securities Exchange, and opened its Middle East office in Riyadh (HKEK). The exchange now has 20 recognised stock exchanges, 33 reviewed overseas jurisdictions, and six overseas offices.

For Canadian issuers, this trend is relevant given the established regulatory co-operation and listing recognition framework between Canada and Hong Kong. Canada is a recognized acceptable jurisdiction under HKEX’s overseas issuer regime, and issuers listed on the TSX and TSXV may leverage their existing Canadian corporate governance, continuous disclosure, and securities law compliance framework when pursuing a Hong Kong listing. This recognition framework has historically been important for Canadian issuers seeking access to Asian capital, particularly where there is a strong nexus to Asia through assets, operations, strategic investors, or end-market demand.

In practice, the protocol and regulatory co-operation between Canadian securities regulators and HKEX have helped streamline the listing process for eligible Canadian issuers by reducing duplication in certain disclosure and governance requirements and providing greater familiarity to Hong Kong regulators and investors with Canadian reporting standards. For Canadian companies with international growth ambitions, this framework continues to position HKEX as a credible secondary or dual-listing venue alongside an existing Canadian listing.

Institutional and retail depth

The depth of investor participation on HKEX is a key differentiator. Over 270 investors across multiple categories participated as cornerstone investors in Hong Kong IPOs in 2025, with 40 IPOs, including international cornerstone investors (HKEX, Bloomberg, and Dealogic). Approximately 50% of the most active investors were international participants, which included Asian and Middle Eastern sovereign wealth funds that have been among the most active investors in HKEX IPOs.

Retail investor participation in Hong Kong IPOs has remained exceptionally strong. For the IPOs completed in 2025, average retail subscription levels reached approximately 1,514 times, with aggregate retail demand totalling approximately US$2.1 billion (HKEX and Dealogic). This depth of retail participation provides important support for IPO execution, valuation, and secondary market liquidity.

Access to Mainland Chinese capital through Stock Connect

One of HKEX’s key advantages is its connectivity to Mainland Chinese investors through the Stock Connect program. Eligible Hong Kong-listed companies can be traded directly by investors in Mainland China through the Shanghai and Shenzhen exchanges, providing access to one of the world’s largest pools of retail and institutional capital. For Canadian issuers, potential inclusion in Stock Connect can materially expand the investor base, enhance trading liquidity, and increase visibility with Asian investors.

Post-IPO capital raising and an active follow-on market

One of the more attractive features of the Hong Kong market is the depth of its post-IPO follow-on financing market. Of the 41 IPO issuers since 2024, with deal sizes above US$100 million, approximately 37% completed follow-on offerings after listing with several issuers raising more capital in subsequent financings than in their IPOs (HKEX, Bloomberg, and Dealogic). On average, issuers accessed the follow-on market approximately eight months after listing, shortly after the expiry of IPO lock-up periods.

For issuers, this demonstrates that a Hong Kong listing can serve not only as an initial capital raise, but also as an established platform for future follow-on and secondary fundraising.

Recent regulatory reforms

HKEX has undertaken a series of significant regulatory reforms that enhance the attractiveness of the market for prospective issuers:

IPO price discovery and retail allocation: Following a consultation process that concluded in early 2025, HKEX has implemented reforms to the IPO pricing and allocation mechanism, including a requirement that at least 40% of shares be allocated to the bookbuilding tranche and a new option for issuers to adopt a fixed retail allocation ranging from 10% to 60% (HKEX Consultation Conclusions).

Revised public float requirements: HKEX has introduced a tiered public float threshold based on expected market value at listing: 25% for issuers with market capitalisation up to HK$6 billion; the higher of 15% or HK$1.5 billion for market capitalisations between HK$6 billion and HK$30 billion; and the higher of 10% or HK$4.5 billion for market capitalizations exceeding HK$30 billion. This tiered approach provides significantly greater flexibility for larger issuers. A new free float requirement of at least 10% (with a market value of the free float portion of at least HK$50 million) has also been introduced.

Alternative fund listing: In February 2025, the SFC issued a circular clarifying the regulatory requirements for authorizing closed-ended alternative funds for listing under Chapter 20 of the Main Board Listing Rules, effectively creating a new listing category.

Confidential filing: Following the launch of the TECH in May 2025, Chapter 18A (Biotech) and Chapter 18C (Specialist Technology) issuers may now submit application proofs on a confidential basis, reducing premature disclosure of proprietary technologies and business strategies during the pre-listing process.

Renewed China and Canada engagement

The recent stabilization in diplomatic and trade relations between Canada and the People’s Republic of China may create a more constructive environment for renewed cross-border investment activity, particularly through the HKEX. As relations between the two countries continue to improve, companies with both Canadian and Chinese ownership may have greater opportunities to pursue listings on the HKEX.

Historically, a number of Canadian companies, particularly in the mining, energy, and financial services sectors, have successfully completed listings on the HKEX. These transactions demonstrated Hong Kong’s role as an effective gateway for Canadian issuers seeking access to Asian capital, particularly where there is a meaningful China or broader Asia-related business nexus. The precedent established by these listings may serve as a useful framework for renewed Canada–China cross-border investment and capital markets activity as bilateral relations continue to improve.

From a broader investment perspective, improving geopolitical relations may also lead to a more balanced regulatory approach toward minority Chinese investments in Canadian businesses, including in sectors that have previously faced scrutiny under the Investment Canada Act and on the basis of national security considerations. While careful structuring will remain important, current conditions suggest a more favourable environment for Canadian and Chinese companies to pursue joint investment opportunities across capital markets, technology, industry, and natural resources.

Key considerations for Canadian issuers

Several factors make this an attractive time for Canadian issuers to consider a Hong Kong listing. Most notably, HKEX provides access to a deep and increasingly international pool of capital tied to Asia’s long-term economic growth, including investors focused on China, Southeast Asia, and the broader Indo-Pacific region. For Canadian issuers, this can provide exposure to sources of institutional, sovereign, and strategic capital that are less accessible through traditional North American markets.

The alignment between Canada’s strengths in mining, technology, energy, and industrial sectors and the sectors currently attracting capital on HKEX is also significant, particularly for companies with operations, customers, supply chains, or growth ambitions in Asia. In addition, recent regulatory reforms, including more flexible listing requirements and streamlined processes for technology and biotech companies, should improve market accessibility for international issuers.

With a strong IPO pipeline and continued investor demand supporting new issuance activity, HKEX remains well-positioned as a complementary capital markets pathway for Canadian companies seeking broader international investor access and diversification beyond North America.

DLA Piper and next steps

DLA Piper’s global platform, with offices in Canada, Hong Kong, and across Asia (including Mainland China), is uniquely positioned to advise Canadian issuers on cross-border listing transactions. Our capital markets team has experience in structuring and executing dual listings for Canadian and international issuers, navigating HKEX’s regulatory framework, and coordinating with underwriters in Hong Kong.

We would be pleased to discuss how a Hong Kong listing could fit within your broader capital markets strategy.

For further information, please contact Raj Dewan or Stephen Wortley.